by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Glioma; Diffuse Glioma; Recurrent Gliomas Interventions: Drug: Oral Vorasidenib administered once daily for up to 12 treatment cycles (28 days per cycle) as IDH-targeted therapy in participants with recurrent or residual IDH-mutant diffuse glioma....
by palligoelme@gmail.com | Mar 13, 2026 | Clinical Trials
Conditions: Acculturative Stress; Mental Health Interventions: Behavioral: STRONG; Behavioral: Learning Collaborative Sponsors: University of Oregon Not yet recruiting Conditions: Acculturative Stress; Mental Health Interventions: Behavioral: STRONG; Behavioral:...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Infertility Interventions: Behavioral: Levin’s conservative model- based nursing care Sponsors: Fayoum University; Menoufia University Completed Conditions: Infertility Interventions: Behavioral: Levin’s conservative model- based nursing care...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Spinal Cord Injuries Interventions: Device: tsDCS+pDCS; Device: Low-level laser therapy Sponsors: Spaulding Rehabilitation Hospital; PathMaker Neurosystems Inc.; Erchonia Corporation Completed Conditions: Spinal Cord Injuries Interventions: Device:...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Cardiovascular Disease Interventions: Device: Non-invasive Smart Mattress Monitoring System Sponsors: Beijing Anzhen Hospital Recruiting Conditions: Cardiovascular Disease Interventions: Device: Non-invasive Smart Mattress Monitoring System Sponsors:...
by palligoelme@gmail.com | Mar 12, 2026 | Clinical Trials
Conditions: Chronic Stroke; CONUT Score; Balance Assessment; Functional Status Sponsors: Marmara University Recruiting Conditions: Chronic Stroke; CONUT Score; Balance Assessment; Functional Status Sponsors: Marmara University...
